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A B S T R A C T
Interferon-gamma (IFN-g) and interleukin (IL)-10 are cross-regulatory cytokines capable
of driving and controlling the adaptive host immune response. The inter-relationship
between IFN-g and IL-10 expression has not been deﬁned in sheep despite biological
evidence suggesting that they perform similar functions to their orthologues described in
other species. To address this, we have developed a quantitative (q)PCR method to assess
relative levels of IFN-g and IL-10 mRNA expression in activated ovine peripheral blood
mononuclear cells (PBMC) and compared the kinetics of mRNA expression with amounts
of cytokine secreted by the cells over a 96 h period. PBMC were collected from sheep
immunised with the nominal antigen ovalbumin (Ova) and re-stimulated in vitro with
antigen and the T cell mitogen concanavalin A (ConA). The recall response to antigen was
characterised by a single peak in IFN-g mRNA expression at 48 h of culture (13-fold
increase over unstimulated cells) and relatively lower expression of IL-10 mRNA (average
2–3-fold increase over the 96 h culture period). Antigen-driven IFN-g protein concentra-
tion was greatest at the end of the culture period (96 h) whereas IL-10 protein level was
not elevated above that observed in unstimulated cells. The typical response to ConA was
greater for both cytokines, with IFN-gmRNA expression peaking at 6 h of culture (133-fold
increase) then declining rapidly whereas IL-10 mRNA expression peaked at 24 h (16-fold
increase) and declined more gradually. Despite these differences in the relative kinetics of
mRNA expression in mitogen-activated PBMC, the typical pattern of protein expression of
the two cytokines was similar. Both showed a gradual rise in protein concentration
starting from 12 h of culture which was still rising at the end of the culture period (96 h).
These data demonstrate that the kinetics of mRNA expression for IFN-g and IL-10 in
activated ovine PBMC do not necessarily correlate with detectable protein in culture.
Contents lists available at ScienceDirect
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Cytokine biology is central to T cell function and the
development of adaptive immune responses ‘tailored’ for
controlling different types of pathogens. The ﬁrst descrip-
tion of two distinct types of CD4+ve T helper(h) clones (Th1* Corresponding author. Tel.: +44 131 445 5111; fax: +44 131 445 6235.
E-mail address: sean.wattegedera@moredun.ac.uk (S.R.Wattegedera).
0165-2427/$ – see front matter  2010 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetimm.2010.02.004and Th2) in mice was based on their mutually exclusive
cytokine proﬁles, with Th1 cells producing interferon-
gamma (IFN-g) and Th2 cells producing interleukin (IL)-4
(Mosmann et al., 1986). These ﬁndings led to the
establishment of one of the most important paradigms
of modern immunology, namely that Th1/Th2 subsets
cross-regulate throughmutual inhibition. It was studies on
the mechanistic nature of this inhibition that led to the
discovery of ‘cytokine synthesis inhibitory factor’ (CSIF),
now known as IL-10 (Bashyam, 2007; Fiorentino et al.,
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synthesis and therefore regulate inﬂammatory immune
responses. The importance of IL-10-mediated immune
regulation is exempliﬁed by the lethal, uncontrolled
immune responses in IL-10 knock-out mice infected with
the protozoan pathogen Toxoplasma gondii, a strong driver
of the inﬂammatory immune response (Gazzinelli et al.,
1996). CD4+ve T cell subset differentiation and cross-
regulation are now known to be much more complex than
the original Th1/Th2 paradigm. Regulatory T cells (Treg),
Th17 and the recently described Th9 subset, all of which
express deﬁned cytokine proﬁles, have been described in
mice (Veldhoen et al., 2008; Zhu and Paul, 2008).
The capability to measure cytokine production and
deﬁne function is essential for investigating the develop-
ment of host immune responses and understanding
disease pathogenesis. It is well recognised that the
capability to study Th subsets and deﬁne immunoregula-
tory pathways in veterinary species lags behind that of
mouse and human to the extent that we do not know if the
subsets even exist in other species. Such a knowledge gap
clearly impacts on vaccine design and disease control,
particularly in light of that fact that there is growing
evidence to suggest that mechanisms of immune activa-
tion and immunological paradigms established in rodents
do not necessarily translate to other mammalian species
(Kirman and Seder, 2003; Wattegedera et al., 2008).
The cloning and expression of cytokines, and other
immunoregulatory molecules, from several veterinary
species have accelerated in recent years (Entrican et al.,
2009). However, invariably, molecular probes to study
mRNA expression are developed and exploited long before
antibodies are produced (and properly characterised) to
measure protein production. Consequently, the measure-
ment of gene transcription is more commonly measured
than protein production. The potential shortcoming of the
molecular approach alone is the difﬁculty of inferring
levels of protein production from mRNA expression.
Ideally, it is desirable to have the capability to quantify
both mRNA expression and protein production for any
given molecule of interest to reliably deﬁne the kinetics of
cytokine induction. With a view to expanding this
capability in sheep, we report here on the development
of quantitative (q)PCR to measure relative expression of
mRNA encoding IFN-g and IL-10 in mitogen-driven and
antigen-speciﬁc recall responses of peripheral blood
mononuclear cells (PBMC) and compare this expression
with protein production over time.
2. Materials and methods
2.1. Animals
Eight, three-and-a-half-year-old, female Scottish Black-
face ewes derived from the breeding stock at Moredun
Research Institute were maintained on pasture. The ewes
were immunised with chicken egg ovalbumin (Ova) two
years prior to this study. Brieﬂy, the immunisation protocol
consisted of a sub-cutaneous primary injection of 1ml
containing1mgof the nominal antigen (Ova; Sigma,Dorset,
UK) emulsiﬁed in complete Freund’s adjuvant (Sigma)followed by a 1ml booster immunisation four weeks later
consisting of 0.5mg Ova emulsiﬁed in incomplete Freund’s
adjuvant (Sigma). These ewes had demonstrable antigen-
speciﬁc cellular recall responsesup toeighteenmonthsafter
immunisation (Wattegedera et al., 2008).
2.2. Lymphocyte stimulation assay (LSA)
PBMC were prepared from 30ml of blood collected
from the jugular vein according to a previously described
protocol (Wattegedera et al., 2004). The cells were
adjusted to a ﬁnal concentration of 2 106 cells/ml in
500ml of Iscove’s Modiﬁed Dulbecco’s medium (Gibco,
Paisley, UK) supplemented with 10% FBS (PAA, Hanninger,
Austria), 50mg/ml gentamycin (Aventis Pharma Ltd., Kent,
UK) and 50mM b-mercaptoethanol (Sigma) and seeded in
24-well ﬂat-bottom tissue culture plates (Costar, Corning,
NY, USA). 500ml of Ova at 20mg/ml, 500ml of ConA
(extract from Concanavalia ensiformis, ICN Biochemicals,
Cleveland, OH, USA) at 10mg/ml (positive control), or
500ml of culture medium (unstimulated negative control)
were added to the cells to give a ﬁnal volume of 1ml per
well and the cells were cultured at 37 8C/5% CO2 in a
humidiﬁed incubator. Cells and culture supernatant were
harvested at 6, 12, 24, 48, 72 and 96 h. At each of these
time-points, the cells and culture supernatant were
removed to conical centrifuge tubes and centrifuged at
290 g, 4 8C for 5min. The cell-free supernatant was
removed and stored at 20 8C until analysis for cytokines.
The cell pellet was re-suspended mechanically using cell
lysis buffer (Qiagen, West Sussex, UK) containing b-
mercaptoethanol (Sigma) to produce cell lysates which
were then stored at 20 8C. Samples representing a time
zero sample point of unstimulated cells in culture medium
alone were harvested as baseline controls.
2.3. Analysis of culture supernatant by ELISAs
Culture supernatants were tested for IFN-g using the
BOVIGAMTM commercial ELISA (Prionics, Schlieren-Zurich,
Switzerland), according to themanufacturer’s instructions.
Quantiﬁcation was performed using a standard curve
generated using known concentrations of recombinant
bovine IFN-g (kindly supplied by Dr. Steven Jones, Pﬁzer
Animal Health, Parkville, Australia). IL-10 was detected by
ELISA using the monoclonal antibodies (mAbs) CC318 and
CC320 (Kwong et al., 2002). Quantiﬁcation was performed
using recombinant bovine IL-10 expressed in Chinese
Hamster Ovary (CHO) cells using the pEE141 expression
vector according to a previously published protocol
(Wattegedera et al., 2004). The IL-10 mAbs and recombi-
nant protein were generated and provided within the
BBSRC/RERAD Immunological Toolbox Consortium (http://
www.immunologicaltoolbox.com/).
2.4. Preparation of cDNA
Total RNA was prepared from cell lysates using an
RNeasy1 Mini Kit (Qiagen, West Sussex, UK) according to
the manufacturer’s instructions, including the additional
on-column DNaseI digestion step to remove contaminating
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visualisation under UV light of the 28S and 18S bands from
each RNA sample with 1ml run on an agarose gel. 15ml of
RNA from each sample was reverse-transcribed using a
High-Capacity cDNA Archive Kit (Applied Biosystems,
Warrington, Cheshire, UK) according to the manufacturer’s
instructions and then stored at 20 8C.
2.5. Primer and probe design and optimisation for qPCR
Details of the primers and probes for ovine glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH), ovine
IFN-g and ovine IL-10 are shown in Table 1. Sense and
antisense primers were predicted to be located in two
consecutive exons of the respective genes. The IFN-g
TaqMan1 probe, containing the VIC1 reporter dye and 6-
carboxytetramethylrhodamine (TAMRATM) was designed
to span the junction of two exons to ensure discrimination
between cDNA and possible contaminating genomic DNA.
Since no exon/intron information is available for ovine IFN-
g, the primers and probe were designed by aligning the
ovine and bovine IFN-g sequences, accession numbers
X52640 and M29867 respectively (Genbank), and then
modifying the previously described primers and probe for
bovine IFN-g (Leutenegger et al., 2000). The IL-10 Taq-
Man1 probe, containing the VIC1 reporter dye and 6-
carboxytetramethylrhodamine (TAMRATM) was designed
from the ovine cDNA sequence (Dutia et al., 1994).
TaqMan1 qPCR was carried out using the ABI PRISM
7000 Sequence Detection System (SDS). Primer and probe
concentrations were optimised for all genes following the
Applied Biosystems protocol using complementary
(c)DNA. For the cytokine targets, the cDNA was derived
from transfected CHO cells expressing ovine IFN-g or ovine
IL-10. For GAPDH, the cDNA was derived from the ovine
adenocarcinoma ST-6 cell line (Norval et al., 1981).
2.6. qPCR protocol
Three separate qPCR reactions were conducted using
5ml of cDNA from each sample and each of the IFN-g, IL-10
or GAPDH primers and probes. TaqMan1 Universal PCR
Master Mix (Applied Biosystems) was used at the
recommended concentration. Each sample was assayed
in triplicate using thermal cycling conditions of 50 8C forTable 1
Quantitative PCR primer/probe sequences for ampliﬁcation and detection of ta
Target Primer/probe Sequence (50–30)
GAPDHa Fwd GCATCGTGGAGGGACTTATGA
Rev GCCATCACGCCACAGCTT
Probe (6-FAM)-CACTGTCCACGCCATCACTGCCA-(TAM
Fwd TGGATATCATCAAGCAAGACATGTT
IFN-g Rev GGTCATTCATCACCTTGATGAGTTC
Probe (VIC)-CAGATCATCCACCGGAATTTGAATCAGCA
Fwd GAGCTGCCTTCGGCAAAGT
IL-10 Rev CCCTTAAAGTCATCCAGCAGAGA
Probe (VIC)-AAGACTTTCTTTCAAATGAAGGACCAACTG
Key: Fwd, forward; Rev, reverse; 6-FAM, 6-carboxyﬂuorescein; TAMRA, 6-carb
a Primers and probe designed by Dr. Christina Cousens (Moredun Research I2min, 95 8C for 10min and 40 cycles of 95 8C for 15 s and
60 8C for 1min. Experimental samples from each time-
point were analysed on the same 96-well plate to reduce
within sample-point variation. Analysis was performed
using the ABI Prism 7000 SDS software 1.2.3.
2.7. Validation of qPCR and application of relative
quantiﬁcation method
Data were quantiﬁed using relative quantiﬁcation by
the comparative cycle threshold (CT) method (Cikos et al.,
2007). To validate this quantiﬁcation method, the ampli-
ﬁcation efﬁciencies of the experimental targets (IFN-g and
IL-10) need to be approximately equal to the ampliﬁcation
efﬁciency of the reference target (GAPDH). A serial dilution
of an experimental samplewas used for this validation. The
log2 input was plotted versus DCT (target–reference) for
each cytokine giving differences in the slope values of less
than 0.2 (data shown in Table 1). The comparative CT
methodwas then used to determine the relative difference
in cytokine expression between stimulated and unstimu-
lated cells, using the cells cultured in medium alone as the
calibrator.
GAPDH has been shown to serve as an appropriate
calibrator housekeeping gene for quantitative analyses
(Montagne et al., 2001; Tudor et al., 2009). The ampliﬁca-
tion of the GAPDH gene for each test sample was used to
standardise the amount of template DNA present in each
reaction and optimised for use in this experimental
system. The arithmetic mean of three CT values for each
of the eight samples (each ewe) for treatment against time
was calculated and transformed using the formula 40-CT.
The transformed value (40-CT) value was the plotted for
treatment over time and the higher values represented
greater amounts of cytokine mRNA (Fig. 1). This process
demonstrated that GAPDH gene expression varied with
different treatments as shown by the divergence of the
lines extending over time for the experimental samples. It
was not possible to attributemRNA expression on a per cell
basis from the cell harvesting protocol and therefore it was
necessary to remove the inﬂuence of proliferating cells on
the gene expression values. To achieve this, the cytokine
gene expression CT values were normalised against the
most appropriate baseline (GAPDH CT values for each
treatment at each time-point), givingDCT values. TheDDCTrget and endogenous genes.
Slope of log2 versus DCT
(cytokine-GAPDH)
Genbank accession
number/reference
n/a AF035421
RA)
0.0418 X52640/M29867
-(TAMRA)
0.1704 Dutia et al. (1994)
AACA-(TAMRA)
oxytetramethylrhodamine.
nstitute).
Fig. 1. GAPDHmRNA expression in activated ovine PBMC. PBMC collected
from eight sheep were re-stimulated in vitro with antigen (Ova, ~) or
mitogen (ConA,&). Unstimulated PBMC (medium alone, *) served as a
negative control. Total RNAwas prepared from cell lysates as described in
Section 2 and GAPDH mRNA expression (represented by 40-cycle
threshold; 40-CT) measured by real-time TaqMan
1 PCR. Error bars
represent the standard error of the arithmetic mean of PBMC from eight
sheep at each time-point.
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sample DCT, and the fold-change determined by the
equation 2DDCT (Cikos et al., 2007).
2.8. Statistical analyses
The qPCR data were transformed using the DDCT
method and responses to Ova and ConA for each animal
were compared using a repeatedmeasuresmodel. The lack
of independence between successivemeasurements on the
same animal was modeled using an AR(1) power model.
Data for IFN-g and IL-10 expression were analysed
separately.
The ELISA data showed increasing variability with
higher values and also contained many zero readings that
were unsuitable for inclusion in a simple repeated
measures model. The data were analysed using the area
under the response curve (AUC) method with respect to
time for both Ova and ConA and the log of the AUC values
used in the subsequent analyses. The difference between
the mean values for Ova and ConAwere investigated using
a paired t-test separately for IFN-g and IL-10.
All data were analysed using the one-sample t-test or
REML directive in Genstat 10th Edition.
3. Results
3.1. Comparative expression of mRNA encoding IFN-g and
IL-10 by activated PBMC
The levels of IFN-g and IL-10mRNA expression in PBMC
prior to normalisationwith GAPDH are shown in Fig. 2. The
mean CT values have been transformed by deducting the
number from 40. The transformed values (40-CT) have
been used to generate the box and whisker plots. The
baseline values for cytokine mRNA expression were
derived from unstimulated PBMC and higher 40-CT
correspond to greater mRNA expression. It can be seen
that there is inter-animal variation in both IFN-g and IL-10
mRNA expression in unstimulated cells over time, withgreater inter-animal variability in IL-10 expression at time
zero, as shown by the inter-quartile range of the box and
whisker plots (Fig. 2a and d).
The patterns of IFN-g mRNA expression over the time-
course of the experiment differ between unstimulated
cells (Fig. 2a), the Ova-stimulated cells (Fig. 2b), represent-
ing the speciﬁc antigen recall response and the mitogen
(ConA)-stimulated cells (Fig. 2c), representing a polyclonal
response, with highly signiﬁcant changes in mean IFN-g
mRNA expression in response to Ova and ConA (p< 0.001)
over time. The Ova-speciﬁc recall response induces IFN-g
mRNA expression that increases at a steady rate over time
to a plateau at 72–96 h (Fig. 2b). In contrast, ConA rapidly
induces a high level of IFN-gmRNA expression by 6 h, with
little deviation over the course of the experiment (Fig. 2c).
The levels of expression of mRNA encoding IL-10 are
generally lower than those for IFN-g, irrespective of
time-point or treatment (Fig. 2a–f). Interestingly, the level
of IL-10 mRNA expression in the Ova-stimulated cells is
almost non-existent and indistinguishable from unstimu-
lated cells (Fig. 2d and e), which is different from the
pattern observed for IFN-g. However, as for IFN-g, IL-10
mRNA is rapidly expressed in response to ConA (within
6 h) and remains at the same level for the course of the
experiment (Fig. 2f).
3.2. Comparative production of IFN-g and IL-10 protein by
activated PBMC
The levels of IFN-g and IL-10 in the culture super-
natants of unstimulated cells were very low and close to
the detection limits of the respective ELISAs, as described
in the legend of Fig. 3. As for the mRNA expression,
differences in protein production between the two
cytokines were observed following antigen re-stimulation
or mitogen activation of PBMC (Fig. 3). Both antigen and
mitogen stimulation of PBMC induced highly signiﬁcant
changes in mean IFN-g production over time (p< 0.001).
Ova-speciﬁc IFN-g was ﬁrst detected in the 48 h culture
supernatants and mean levels continued to increase over
the course of the experiment, with intra-animal variability
most evident at 72 and 96 h (Fig. 3a). In contrast to the
antigen-speciﬁc recall response, IFN-gwas detected earlier
in the culture supernatants of the ConA-activated cells
(12 h), continuing to accumulate in the culture super-
natants at a steady rate to the 96 h sample point.
Appreciable intra-animal variability was evident from
48 h onwards (Fig. 3b).
There was very little antigen-speciﬁc production of IL-
10. Although there was a trend towards increasing
amounts as the experiment progressed, the levels of IL-
10 in the supernatants of the Ova-stimulated PBMC were
close to the detection limit of the ELISA and indistinguish-
able from those derived from unstimulated PBMC at all
time-points (Fig. 3c). As for IFN-g, IL-10 began to appear in
the culture supernatants of mitogen-activated PBMC at
12 h and levels continued to increase over the course of the
experiment (Fig. 3d). Unlike Ova stimulation, ConA
stimulation induced highly signiﬁcant changes in mean
IL-10 production over time (p< 0.001). There was clear
intra-animal variation in the mitogen-induced IL-10, with
Fig. 2. IFN-g and IL-10 mRNA expression in activated ovine PBMC. PBMC collected from eight sheep were re-stimulated in vitrowith antigen (Ova; b and e)
or mitogen (ConA; c and f). Unstimulated PBMC (medium alone; a and d) served as negative controls. Total RNAwas prepared from cell lysates as described
in Section 2 and IFN-g and IL-10mRNA expression (represented by 40-cycle threshold; 40-CT) measured by real-time TaqMan
1 PCR. Boxplots represent the
inter-quartile ranges of the individual data points from the group of eight animals. The box bottom represents the 1st quartile (Q1) and the box top the 3rd
quartile (Q3) value. The horizontal line through each box represents themedian value and^ denotes the arithmetic mean.Whiskers extend to the highest/
lowest value within the outlier limits, set at the points Q1–1.5(Q3–Q1) and Q3 + 1.5(Q3–Q1). Outliers (*) are those values falling outside the outlier limits.
S.R. Wattegedera et al. / Veterinary Immunology and Immunopathology 136 (2010) 34–4238outlier animals being identiﬁed by the statistical algorithm
(Fig. 3d).
3.3. Correlation of cytokine mRNA expression with protein
production using the relative quantiﬁcation method
The CT values shown in Fig. 2 for cytokine mRNA
expression in PBMC over time were all relative to the
unstimulated cells harvested at time zero. To ensure that
the intra- and inter-sample-point differences were not
simply due to variations in cell numbers, CT values for
unstimulated PBMC were deducted from CT values for the
corresponding antigen- or mitogen-activated PBMC at
each time-point and normalised to the equivalent GAPDH
CT value to give fold-changes in cytokine mRNA expression
relative to GAPDH (Fig. 4).
Using this adjustment to allow the direct comparisons
to be made, it can be seen that there was a marked
difference between the pattern and magnitude of IFN-g
mRNA expression and protein production by PBMC
stimulated with Ova and ConA (Fig. 4a). In ConA-activated
PBMC, the peak mean mRNA expression occurred at 6 h
(133-fold increase compared to unstimulated cells),
dropped rapidly by 12 h (39-fold increase) then continued
to decline steadily to a 2.3-fold increase by 96 h. In
contrast, the mean amount of IFN-g protein in thesupernatants of the same cultures was greatest at 96 h,
the point of lowest mRNA expression. In the antigen-
stimulated PBMC, IFN-g mean mRNA expression peaked
later at 48 h (13-fold increase), decreasing to a 6.0-fold
mean increase by 96 h (Fig. 4a). As with the ConA-
stimulated cells, the greatest mean amount of IFN-g was
found in the 96 h culture supernatant.
The expression proﬁle for IL-10 following ConA activa-
tion differed from that observed for IFN-g. At the 6 h time-
point (the peak for IFN-g) there was a mean 9.4-fold
increase in the level of IL-10 mRNA expression. However,
this continued to rise to a peak at 24 h (16-fold increase)
which was both relatively later and lower than that
observed for IFN-g (Fig. 4b). The mean levels of IL-10
mRNA declined less rapidly than those of IFN-g but had
decreased to a similar level by 96 h (2.7-fold increase).
Despite the different kinetics of IFN-g and IL-10 mRNA
expression in ConA-activated cells, the relative patterns of
protein expression for both cytokines were almost
identical (Fig. 4a and b). For Ova-stimulated PBMC, a
modest but signiﬁcant (p< 0.001) increase in mean IL-10
mRNA expressionwas observed for each sample point over
the time-course of the experiment, with the lowest being a
1.8-fold mean increase (24 h) and the highest a 3.3-fold
mean increase (6 h). The amounts of IL-10 protein in the
Ova-stimulated PBMC culture supernatants were close to
Fig. 3. IFN-g and IL-10 protein expression by activated ovine PBMC. PBMC collected from eight sheepwere re-stimulated in vitrowith antigen (Ova; a and c)
ormitogen (ConA; b and d). Culture supernatantswere harvested as described in Section 2 and IFN-g and IL-10 protein expressionmeasured by ELISA. IFN-g
was quantiﬁed against a recombinant bovine IFN-g standard and expressed as pg/ml. IL-10was quantiﬁed against a recombinant bovine IL-10 standard and
expressed as biological units per ml (bU/ml). Boxplots represent the inter-quartile ranges of individual data points from the group of eight animals. The box
bottom represents the 1st quartile (Q1) and the box top the 3rd quartile (Q3) value. The horizontal line through each box represents themedian value and^
denotes the arithmetic mean. Whiskers extend to the highest/lowest value within the outlier limits, set at the points Q1–1.5(Q3–Q1) and Q3 + 1.5(Q3–Q1).
Outliers (*) are those values falling outside the outlier limits. Plots for unstimulated cells are not shown since values were very low. Neither cytokine was
detectable at 6 h. IFN-gwas also undetectable in the 12, 24 and 48 h culture supernatants. At 72 and 96 h, the average values for IFN-gwere 24 and 83 pg/ml
respectively. The concentrations of IL-10 at 12, 24, 48, 72 and 96 h were 0.07, 0.13, 0.20, 0.24 and 0.23 bU/ml respectively.
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unstimulated cells.
4. Discussion
Hypothesis-driven research into host–pathogen inter-
actions and identiﬁcation of immunological correlates of
protection are dependent on having the appropriate tools
and reagents to answer speciﬁc research questions. The
range of tools to conduct such studies in veterinary species
has expanded greatly in recent years. However, many gaps
in our capabilities still remain, and although we can infer
immune function from comparative data across species, it
is not reliable to make broad assumptions (Entrican et al.,
2009). To address one of the gaps in our understanding of
cytokine inter-relationships in sheep, we report here on
the kinetics of ovine IFN-g and IL-10 mRNA and protein
expression during antigen-speciﬁc recall responses and
mitogenic activation of PBMC in vitro. Furthermore, we
describe a novel combined quantitative PCR method for
these two cytokines that allows relative analysis of their
gene expression during immune cell activation.
The value of developing a relative quantitative PCR
method based on a housekeeping gene is that it allows
comparisons to be drawn between different targets. WeselectedGAPDH as the housekeeping gene to normalise the
template cDNA since this has been shown previously to be
a suitable reference for normalising ovine cytokine gene
transcription (Montagne et al., 2001). In the Montagne
et al. (2001) study, the GAPDH signal was found to remain
constant between animals, between different organs
(spleen and lymph nodes) and irrespective of infection
status (Salmonella abortusovis) and was therefore consid-
ered suitable to be used as a reference to quantify ovine IL-
1b, IL-4, IL-12, TNF-a and IFN-g expression using a
competitive PCR method. However, a more recent study
(Budhia et al., 2006) compared GAPDH and ATPase (among
others) as housekeeping genes for quantifying the
expression of the same cytokines by quantitative PCR.
When using ConA-activated ovine PBMC to validate their
method, they found differential expression of these
housekeeping genes between unstimulated and ConA-
activated ovine PBMC over time when normalised against
total RNA and input cell number. In keeping with those
ﬁndings, we also found that mean GAPDH expression
differed between ConA-stimulated and unstimulated
PBMC and also changed over time. The most likely
explanation is that increasing GAPDH expression is
reﬂective of increasing numbers of cells due to prolifera-
tion in response to mitogenic activation. Normalising
Fig. 4. Quantitative comparison of IFN-g and IL-10 mRNA and protein expression by activated ovine PBMC. PBMC collected from eight sheep were re-
stimulated in vitrowith antigen (Ova,~/~) or mitogen (ConA,&/&). Total RNA was prepared from cell lysates as described in Section 2. IFN-g, IL-10 and
GAPDHmRNA expression weremeasured by real-time TaqMan1 PCR. IFN-g (a) and IL-10 (b) were quantiﬁed by normalisation against GAPDHwithin each
treatment for each time-point and values shown as fold-change relative to unstimulated PBMC (medium alone). IFN-g (a) and IL-10 (b) protein expression
were measured by ELISA. IFN-g was quantiﬁed against a recombinant bovine IFN-g standard and expressed as pg/ml. IL-10 was quantiﬁed against a
recombinant bovine IL-10 standard and expressed as biological units per ml (bU/ml). mRNA is represented by open symbols (& and ~), protein is
represented by closed symbols (& and ~). Error bars represent the standard error of the arithmetic mean.
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the principle aim of our study was to develop a capability
to examine the relative kinetics of IFN-g and IL-10 mRNA
expression (and protein) over time, we normalised against
GAPDH within each treatment at each time-point and not
simply against total RNA. This allowed reliable compar-
isons to be drawn between the cytokines as the cells
proliferated.
Taking this approach, it can be seen from Fig. 4 that IFN-
g mRNA expression peaks earlier and at a higher mean
relative level than mRNA encoding IL-10 in both antigen-
and mitogen-activated ovine PBMC. Despite the different
kinetics of mRNA expression, protein measurements in the
culture supernatants followed an almost identical pattern,
indicating that quantitative mRNA measurements for
these cytokines do not necessarily predict protein produc-
tion (Fig. 4). This is not unique to the cytokines in this
study. Tagaya et al. (1996) found that PMBC stimulated
with LPS and IFN-g strongly up-regulated IL-15mRNA, but
only low amounts of proteinwere detectable by ELISA or in
a CTLL-2 proliferation assay.The patterns of mRNA expression also demonstrate the
impact of sample collection time on the relative expression
of IFN-g and IL-10. For example, in this experimental
system, relative quantiﬁcation of IFN-g versus IL-10mRNA
6 h after ConA activation gives a mean ratio of 14.1:1,
whereas at 12 h themean ratio is 4.5:1 and at 24 h drops to
1.3:1. Thus the early dominance of the IFN-g response over
IL-10 would not be observed in ConA-activated PBMC
harvested at 24 h. In contrast, for antigen-stimulated cells
the greatestmean ratio of IFN-g:IL-10mRNAwas observed
at 48 h (4.8:1). The greater magnitude and speed of the
mitogen-driven response relative to the antigen-driven
response is to be expected, based on the relative numbers
of PBMC responding in each case and the requirement for
antigen processing to occur in the Ova-stimulated cultures
(Figs. 2–4). The low/absent production of IL-10 by the Ova-
stimulated PBMC is in keeping with a previous study
looking at longitudinal cytokine expression in Ova-
immunised ewes where IFN-g predominated (Wattege-
dera et al., 2008). This is likely to be reﬂective of the
immunisation regime used to elicit the Ova-speciﬁc
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plete Adjuvant, a strong promoter of the inﬂammatory host
immune response (Wattegedera et al., 2008).
Other groups have shown that cytokine mRNA expres-
sion tends to peak between 3 and 24 h of mitogenic
stimulation (Budhia et al., 2006; Sullivan et al., 2000)
depending on the host species, cell type and culture
conditions. Whilst measurement of mRNA by qPCR is very
useful in providing relative quantiﬁcation of different
cytokines in an immune response, other factors potentially
play a more signiﬁcant role in the development of
immunity such as mRNA turnover or stability as deter-
mined by post-transcriptional control mechanisms. Post-
transcriptional control of cytokine production is very
complex and dependant onmultiple factors. IL-10 and IFN-
g are known to be regulated by the adenine and uridine-
rich elements binding proteins (ARE-BP) tristetraprolin
(TTP) and Hu antigen R (HuR) respectively. These proteins
positively or negatively regulate mRNA stability and/or
translation to protein depending on other factors in the
microenvironment (reviewed by Anderson, 2008).
Direct comparisons of relative protein expression for
IFN-g and IL-10 were not possible in this study due the
nature of the ELISA standards. The IL-10 ELISA was
calibrated using a recombinant standard that was quanti-
ﬁed in biological units/ml whereas the IFN-g ELISA was
calibrated using a recombinant standard quantiﬁed in pg/
ml. Efforts to address this for bovine and ovine IL-10 are
underway. However, even if using relative quantiﬁcation
as pg/mlwas possible, there is a further factor that needs to
be taken into account when drawing comparisons of
cytokine expression at the protein level as opposed to the
mRNA level. ELISAs will only detect excess cytokine in the
culture supernatants and do not therefore account for
cytokine that has been produced but has not been exported
by the cell or indeed cytokine that has been exported but
then utilised by the cells in culture. Since cytokine receptor
expression is not uniform across different phenotypes
within PBMC, different cytokines will therefore be utilised
at different rates, and thus ELISA measurements will not
therefore necessarily reﬂect the amount of protein being
produced.
IFN-g is a marker of innate immune activation and of
adaptive immune responses used in several species as an
indicator of polarisation of CD4+ve T cells to a Th1
phenotype (Zhu and Paul, 2008). Although the Th1/Th2
paradigm has never been deﬁnitively proven in sheep, IFN-
g performs a similar function as it does in other species,
inducing cellular pathways that mediate host immune
control of intracellular pathogens (Rocchi et al., 2009). In
contrast, IL-10 is widely regarded as an immunoregulatory
cytokine. Although IL-10 can interfere with clearance of
intracellular pathogens and therefore be counter-active to
IFN-g in terms of host defence, it also performs a very
important function in reducing or preventing immuno-
pathology resulting from uncontrolled immune activation
(Couper et al., 2008). We have previously shown that IL-10
is capable of regulating mitogen-induced cell proliferation
and IFN-g production by ovine PBMC, suggesting that it
performs a similar cross-regulatory function in sheep as
described for other species (Wattegedera et al., 2004).In conclusion, this is the ﬁrst report of the relative
kinetics of IFN-g and IL-10 mRNA expression in antigen-
and mitogen-activated ovine PBMC and the relationship to
protein in the culture supernatants. The technologies
described here provide a means to deﬁne inﬂammatory
and regulatory immune responses in sheep for two inter-
related cytokines thereby underpinning disease pathogen-
esis studies.
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